Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin after aneurysmal subarachnoid hemorrhage
NL-OMON28808Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Simvastatin with Placebo (2 arms). Primary endpoints: Effect on fibrinolysis, coagulation, inflammation, and endothelial function and Relation between fibrinolytic activity and endothelial cell damage. Started May 2006; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NL-OMON28808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28808.